FDA Hearing. What FDA Failed to Disclose: 1991, 2006.
AHRP Testimony presented by Vera Sharav, December 2006. PowerPoint slides (843 kb file).
Similar Posts
InfoMail for February 19, 2002
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 19, 2002 How a New FDA Policy Led toSeven Deadly Drugs FYI The Seattle Times reports, "Therelationship between the FDA and pharmaceutical industry changed fundamentallyunder former President…
Science Refutes Claims of Drug Benefit: Antipsychotics Found Harmful_NEJM
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."Sen Domenici Blasts NIH doctors calling them "pigs" – The Hill
Sen Domenici Blasts NIH doctors calling them “pigs” – The Hill Thu, 18 Mar 2004 The shameful revelations of insatiable greed among medical researchers at the National Institutes of Health has disgusted Sen. Pete Domenici, one of the strongest supporters of medical research. “I hate to say it, but the…
More Spent on Psych Drugs for preschool kids than antibiotics or asthma – AP
More Spent on Psych Drugs for preschool kids than antibiotics or asthma – AP Mon, 17 May 2004 Data analysis by MEDCO, the nation’s largest prescription benefit manager found that between 2000–2003 there was a 49% increase in the use of psychotropic drugs for children and a 369% increase in…
Cong. Sting: Medical Research Fraud / Corruption /Forged Consents
April 14: the FDA announced that Coast IRB "has agreed to voluntarily halt some aspects of its clinical trial oversight operations due to serious concerns about the company’s ability to protect human subjects participating in clinical trials."
Clinical Trials Controversy Spotlights Flawed System – Psychiatric News
Clinical Trials Controversy Spotlights Flawed System – Psychiatric News Mon, 19 Jul 2004 Recent independent analyses of the published and unpublished SSRI antidepressant pediatric data submitted by manufacturers to the FDA reveal not only that a disparity exists between published and unpublished data, but it becomes increasingly clear that the…